Drugs / Jinfukang oral liquid
Jinfukang oral liquid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05098990 | Oct 2021 → Jun 2024 | non-small cell lung carcinoma | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jinfukang oral liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05098990 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Jinfukang koufuye is a Chinese herbal prescription” NCT05098990 ↗ |
| Route | Oral | “Jinfukang oral liquid will be taken at day 5 after chemotherapy” NCT05098990 ↗ |